##### ยง 10.3 Definitions. #####

Link to an amendment published at 85 FR 80644, Dec. 14, 2020.

For the purposes of this part, the following definitions apply:

*Average Manufacturer Price (AMP)* has the meaning set forth in section 1927(k)(1) of the Social Security Act, as implemented in 42 CFR 447.504.

*Ceiling price* means the maximum statutory price established under section 340B(a)(1) of the PHSA and this section.

*CMS* is the Centers for Medicare & Medicaid Services.

*Covered entity* means an entity that is listed within section 340B(a)(4) of the PHSA, meets the requirements under section 340B(a)(5) of the PHSA, and is registered and listed in the 340B database.

*Covered outpatient drug* has the meaning set forth in section 1927(k) of the Social Security Act.

*Manufacturer* has the meaning set forth in section 1927(k) of the Social Security Act, as implemented in 42 CFR 447.502.

*National Drug Code (NDC)* has the meaning set forth in 42 CFR 447.502.

*Pharmaceutical Pricing Agreement (PPA)* means an agreement described in section 340B(a)(1) of the PHSA.

*Quarter* refers to a calendar quarter unless otherwise specified.

*Secretary* means the Secretary of the Department of Health and Human Services and any other officer of employee of the Department of Health and Human Services to whom the authority involved has been delegated.